MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$38,213K
Net Income
-$17,494K
Net Profit Margin
-45.78%
EPS
-$0.1
Unit: Thousand (K) dollars
Revenue Breakdown
CINVANTI
ZYNRELEF
Aponvie
SUSTOL
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net product sales
38,213
37,200
38,903
45,342*
Cost of product sales
11,914
9,857
8,457
10,274*
Gross profit
26,299
27,343
30,446
35,068*
Research and development
3,470
2,934
2,279
3,288*
General and administrative
13,980
14,471
12,702
16,278*
Sales and marketing
12,942
11,575
12,311
14,169*
Total operating expenses
30,392
28,980
27,292
33,735*
Gain from operations
-4,093
-1,637
3,154
1,333*
Loss on debt extinguishment
-11,339
-
-
-
Other expense, net
-2,063
-744
-519
108*
Interest expense
-
-
-
1,508*
Interest income
-
-
-
888*
Total other (expense) income, net
-
-
-
-513*
Net gain
-17,495
-2,381
2,635
820
Unrealized gain (loss) on short-term investments
1
-2
-12
-
Comprehensive gain
-17,494
-2,383
2,623
820
Basic EPS
-0.1
-0.02
0.02
0.005
Diluted EPS
-0.1
-0.02
0.01
0.005
Basic Average Shares
170,348,000
154,020,000
153,490,000
152,068,000
Diluted Average Shares
170,348,000
154,020,000
196,921,000
152,068,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive gain
-$17,494K
(-264.46%↓ Y/Y)
Unrealized gain (loss) on
short-term investments
$1K
(-97.92%↓ Y/Y)
CINVANTI
$23,955K
ZYNRELEF
$9,313K
Aponvie
$3,034K
SUSTOL
$1,911K
Net gain
-$17,495K
(-260.87%↓ Y/Y)
Net product sales
$38,213K
(16.47%↑ Y/Y)
Loss on debt
extinguishment
-$11,339K
Gain from operations
-$4,093K
(8.19%↑ Y/Y)
Other expense, net
-$2,063K
(-428.97%↓ Y/Y)
Gross profit
$26,299K
(12.62%↑ Y/Y)
Cost of product sales
$11,914K
(25.97%↑ Y/Y)
Total operating
expenses
$30,392K
(9.28%↑ Y/Y)
General and
administrative
$13,980K
(12.99%↑ Y/Y)
Sales and marketing
$12,942K
(17.95%↑ Y/Y)
Research and development
$3,470K
(-22.28%↓ Y/Y)
Buy us a coffee
HERON THERAPEUTICS, INC. DE (HRTX)
HERON THERAPEUTICS, INC. DE (HRTX)